PsychedelicNewsBreaks

WednesdayNov 18, 2020 2:59 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Leverages Distinctive 3-Pillar Strategy to Build Success

Pure Extracts (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and functional mushroom sectors, recognizes the power of a carefully defined, strategic business model. Harvard Business Review touts this importance in an article titled “Why Business Models Matter.” The piece notes that good strategies are defined by answering age-old questions and gaining insight on the customer as well as the fundamentals and underlying economic logic that explains how the business can make money and deliver value in a cost-effective manner. A recent article highlights Pure Extracts’ approach in building a strong business model and “its own distinctive strategy…

Continue Reading

TuesdayNov 17, 2020 3:44 pm

PsychedelicNewsBreaks – Rritual Superfoods Inc. Delivers ‘Daily Dose’ Through Flagship Product Line

Rritual, a plant-based consumer brand, is a natural wellness innovator positioned at the heart of a fledgling industry rife with opportunity. According to Grand View Research Inc., the overall functional foods market is projected to reach $275.77 billion by 2025 (https://ibn.fm/5QUuu), and the demand for nutraceuticals and functional foods is now expected to surge even more than anticipated. Rritual has entered the market with its flagship product line of certified organic mushroom and adaptogen elixir mix powders. The company’s non-psychoactive wellness elixirs include a Chaga blend designed to boost immunity, a Lion’s Mane blend designed to support cognitive function and…

Continue Reading

FridayNov 13, 2020 1:33 pm

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) CEO Talks Company’s Psychedelic Research, Plans on Live Trading Show

Cybin (NEO: CYBN) CEO Doug Drysdale was featured on a recent episode of TraderTV Live. Broadcast live from the DTTW trading floor, TraderTV Live is the first and only professional trading show on YouTube Live. During the show, Drysdale discussed Cybin’s work on psychedelic medical research, including the company’s current phase 2 study. He also provided an overview of Cybin’s strategic plan moving forward in the development process. In addition, Drysdale talked about the company recent listing move to the NEO exchange and plans for an uplisting to a U.S. exchange in the future. “We recently closed our series B…

Continue Reading

ThursdayNov 12, 2020 3:06 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Board Appointment of Dwight Duncan

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, on Tuesday announced the appointment of Dwight Duncan to its board of directors. Duncan serves as a senior strategic advisor at McMillan LLP, a large Canadian full-service business law firm. He also serves as a principal of McMillan Vantage, McMillan LLP’s wholly owned public policy advisory firm, and chairs the board of directors of the Windsor Detroit Bridge Authority, the federal crown corporation overseeing the construction and operation of the $5.7 billion Gordie Howe International Bridge. “We are pleased to welcome Dwight Duncan…

Continue Reading

ThursdayNov 12, 2020 12:43 pm

PsychedelicNewsBreaks – Rritual Receives USDA Organic Certification, Official Confirmation of Product Quality

Rritual announced that it has received the United States Department of Agriculture (“USDA”) Organic Certification. Awarded only after a demanding vetting process, the seal confirms the high quality of Rritual’s product lineup and manufacturing process. Rritual launched its original product lineup in September, which features products formulated with mindfully selected functional mushrooms and adaptogenic herbs. The products are designed to help relieve stress, improve cognitive function and support the immune system. As a Certified Organic company, Rritual meets a strict process that verifies its ingredients are free from antibiotics, toxic pesticides, synthetic hormones and genetically modified organisms (“GMOs”). In addition, Rritual…

Continue Reading

WednesdayNov 11, 2020 10:21 am

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange

Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed a C$45 million subscription receipt financing in relation to its reverse takeover transaction. This signified the largest subscription receipt financing in the Canadian psychedelic sector. “Today marks a meaningful milestone for our company, as our shares begin trading on the NEO Exchange under the ticker…

Continue Reading

FridayNov 06, 2020 11:16 am

PsychedelicNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, 2020, as amended on October 21, 2020. The agreement was among Cybin Corp., Clarmin and 2762898 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the company (the “reverse takeover”), in which the reverse takeover was completed by way of a “three-cornered” amalgamation pursuant to the provisions of the Business Corporations Act (Ontario). Through the reverse takeover, Cybin Corp. amalgamated with SubCo…

Continue Reading

ThursdayNov 05, 2020 10:24 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Commences CSE Trading

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, today announced that, effective immediately, the company’s stock has commenced trading on the Canadian Securities Exchange (“CSE”) under the symbol “PULL.” “There currently is a tremendous consumer demand for natural health products with the ability to immediately enhance our quality of life. With Health Canada officially granting Pure Extracts a Standard Processing License under the Cannabis Act, this has put us on a path to deliver full-spectrum oil products by the end of Q4, 2020,” PULL CEO Ben Nikolaevsky said in a recent…

Continue Reading

MondayNov 02, 2020 2:42 pm

PsychedelicNewsBreaks – Cybin Corp. Paves Path to Profitability with Health-Care Veteran at the Helm

Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://ibn.fm/UTTdr). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than three decades of experience in the health-care sector and will continue to grow the company’s IP portfolio. “With his myriad of business accomplishments, Doug is the ideal leader for Cybin,” stated Cybin co-founder and COO Paul Glavine of the appointment. “We believe that his extensive health-care sector background and international company management skills will help Cybin strengthen partnerships, develop strategic alliances and expand our international…

Continue Reading

FridayOct 30, 2020 2:22 pm

PsychedelicNewsBreaks – Pure Extract Technologies Inc. Leveraging Growing Acceptance of ‘Nature’s Miniature Pharmaceutical Factories’

Pure Extract, a private, plant-based extraction company, is leveraging growing acceptance by mainstream science and the general public to further develop and commercialize functional and medicinal mushroom products on a global scale. World-renowned mycologist Paul Stamets describes mushrooms as “nature’s miniature pharmaceutical factories” (https://ibn.fm/wbYSa). Studied extensively for their various health benefits, current research suggests different varieties of mushrooms may help to improve memory (https://ibn.fm/KUHQ3), mental cognition (https://ibn.fm/dNuo4) and to alleviate the symptoms of depression (https://ibn.fm/YCMQK). Further, “Psychedelic” varieties such as psilocybin – or “magic mushrooms” – are increasingly being studied for possible medical benefits in treating depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease and…

Continue Reading